Invasive Candidiasis in Patients with Solid Tumors: A Single-Center Retrospective Study

References

• Li Y, Gao Y, Niu X, et al. A 5-year review of invasive fungal infection at an academic medical center. Front Cell Infect Microbiol. 2020;10:553648. doi:10.3389/fcimb.2020.553648
   PubMed Web of Science ®Google Scholar
• Enoch DA, Yang H, Aliyu SH, et al. The changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017;1508:17–65. doi:10.1007/978-1-4939-6515-1_2
   PubMedGoogle Scholar
• Ferrarese A, Cattelan A, Cillo U, et al. Invasive fungal infection before and after liver transplantation. World J Gastroenterol. 2020;26(47):7485–7496. doi:10.3748/wjg.v26.i47.7485
   PubMed Web of Science ®Google Scholar
• Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res. 2014;139(2):195–204.
   PubMed Web of Science ®Google Scholar
• Gavaldà J, Meije Y, Len Ó, et al. Infección fúngica invasora en el trasplante de órgano sólido [Invasive fungal infection in solid organ transplant]. Enferm Infecc Microbiol Clin. 2012;30(10):645–653. Spanish. doi:10.1016/j.eimc.2012.09.004
   PubMedGoogle Scholar
• Ruijters VJ, Oosterom N, van der Perk M, et al. Clinical characteristics of invasive fungal infections in pediatric oncology patients with solid tumors. J Pediatr Hematol Oncol. 2021;43(3):e408–e413. doi:10.1097/MPH.0000000000001761
   PubMed Web of Science ®Google Scholar
• Li Y, Wu Y, Gao Y, et al. Machine-learning based prediction of prognostic risk factors in patients with invasive candidiasis infection and bacterial bloodstream infection: a singled centered retrospective study. BMC Infect Dis. 2022;22(1):150. doi:10.1186/s12879-022-07125-8
   PubMed Web of Science ®Google Scholar
• Dandachi D, Wilson Dib R, Fernández-Cruz A, et al. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes. Ann Med. 2018;50(8):713–720. doi:10.1080/07853890.2018.1518581
   PubMed Web of Science ®Google Scholar
• Zirkel J, Klinker H, Kuhn A, et al. Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol. 2012;50(1):50–55. doi:10.3109/13693786.2011.587211
   PubMed Web of Science ®Google Scholar
• Pfisterer N, Lingens C, Heuer C, et al. The microbiome in PDAC-vantage point for future therapies. Cancers. 2022;14(23):5974. doi:10.3390/cancers14235974
   PubMed Web of Science ®Google Scholar
• Koçak U, Rolston KV, Mullen CA. Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia. Support Care Cancer. 2002;10(1):58–64. doi:10.1007/s005200100277
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Busca A, Capparella MR, et al. Invasive candidiasis in patients with solid tumors treated with anidulafungin: a post hoc analysis of efficacy and safety of six pooled studies. Clin Drug Investig. 2021;41(6):539–548. doi:10.1007/s40261-021-01024-7
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366–1377. doi:10.1128/JCM.02117-09
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Gao Y, et al. Prediction of prognostic risk factors in patients with invasive candidiasis and cancer: a single-centre retrospective study. Biomed Res Int. 2022;2022:7896218. doi:10.1155/2022/7896218
   PubMed Web of Science ®Google Scholar
• Orsetti E, Brescini L, Mazzanti S, et al. Central venous catheter unrelated candidemia influences the outcome of infection in patients with solid tumors. Eur J Clin Microbiol Infect Dis. 2019;38(8):1499–1505. doi:10.1007/s10096-019-03578-z
   PubMed Web of Science ®Google Scholar
• Tattevin P, Revest M, Lefort A, et al. Fungal endocarditis: current challenges. Int J Antimicrob Agents. 2014;44(4):290–294. doi:10.1016/j.ijantimicag.2014.07.003
   PubMed Web of Science ®Google Scholar
• Marak MB, Dhanashree B. Antifungal susceptibility and biofilm production of candida spp. isolated from clinical samples. Int J Microbiol. 2018;2018:7495218. doi:10.1155/2018/7495218
   PubMed Web of Science ®Google Scholar
• Gao Y, Tang M, Li Y, et al. Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis. PeerJ. 2022;10:e13594. doi:10.7717/peerj.13594
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Prigitano A, Morroni G, et al. Candidemia: evolution of drug resistance and novel therapeutic approaches. Infect Drug Resist. 2021;14:5543–5553. doi:10.2147/IDR.S274872
   PubMed Web of Science ®Google Scholar
• Pintado MC, Villa P, Luján J, et al. Mortality and functional status at one-year of follow-up in elderly patients with prolonged ICU stay. Med Intensiva. 2016;40(5):289–297. doi:10.1016/j.medin.2015.08.002
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhu R, Luan Z, et al. Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis. BMJ Open. 2020;10(7):e036452. doi:10.1136/bmjopen-2019-036452
   PubMed Web of Science ®Google Scholar
• Wang K, Hsueh K, Kronen R, et al. Creation and assessment of a clinical predictive model for candidaemia in patients with candiduria. Mycoses. 2019;62(7):554–561. doi:10.1111/myc.12917
   PubMed Web of Science ®Google Scholar
• Zatta M, Di Bella S, Giacobbe DR, et al. Clinical features and mortality of nosocomial candidemia in very old patients: a multicentre Italian study. Gerontology. 2020;66(6):532–541. doi:10.1159/000510638
   PubMed Web of Science ®Google Scholar
• Poissy J, Damonti L, Bignon A, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24(1):109. doi:10.1186/s13054-020-2766-1
   PubMed Web of Science ®Google Scholar
• Yalçın N, Sürmelioğlu N, Özkan-Kuşcu Ö, et al. Evaluation of the effect of antibiotics used during parenteral nutrition treatment on Candidemia. Rev Assoc Med Bras. 2021;67(10):1448–1453. doi:10.1590/1806-9282.20210650
   PubMed Web of Science ®Google Scholar
• Cataldo MA, Tetaj N, Selleri M, et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: an alarming “collateral effect”. J Glob Antimicrob Resist. 2020;23:290–291. doi:10.1016/j.jgar.2020.10.004
   PubMed Web of Science ®Google Scholar
• Patel MH, Patel RD, Vanikar AV, et al. Invasive fungal infections in renal transplant patients: a single center study. Ren Fail. 2017;39(1):294–298. doi:10.1080/0886022X.2016.1268537
   PubMed Web of Science ®Google Scholar
• Carvalho AS, Lagana D, Catford J, et al. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health. 2020;25(1):22–29. doi:10.1016/j.idh.2019.08.006
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Rosa DD, Medeiros LR, et al. Candidaemia and cancer: patients are not all the same. BMC Infect Dis. 2006;6:50. doi:10.1186/1471-2334-6-50
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the invasive fungal infection group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28(5):1071–1079. doi:10.1086/514731
   PubMed Web of Science ®Google Scholar
• Lortholary O, Renaudat C, Sitbon K, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652–662. doi:10.1007/s00134-017-4743-y
   PubMed Web of Science ®Google Scholar